29.59
price up icon4.37%   1.24
after-market アフターアワーズ: 29.59
loading
前日終値:
$28.35
開ける:
$28.78
24時間の取引高:
726.22K
Relative Volume:
0.71
時価総額:
$1.73B
収益:
$54.03M
当期純損益:
$-412.78M
株価収益率:
-4.1565
EPS:
-7.1189
ネットキャッシュフロー:
$-377.29M
1週間 パフォーマンス:
+5.19%
1か月 パフォーマンス:
-1.23%
6か月 パフォーマンス:
-19.18%
1年 パフォーマンス:
-3.80%
1日の値動き範囲:
Value
$28.59
$30.16
1週間の範囲:
Value
$27.40
$30.16
52週間の値動き範囲:
Value
$22.24
$46.00

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1114)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
540
Name
Twitter
@AgiosPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

Compare AGIO vs VRTX, REGN, ALNY, ARGX, INSM

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AGIO icon
AGIO
Agios Pharmaceuticals Inc
29.59 1.66B 54.03M -412.78M -377.29M -7.1189
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
454.97 113.96B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
749.47 78.41B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
328.70 40.85B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
697.05 42.05B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.31 29.99B 606.42M -1.28B -997.58M -6.403

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-24 開始されました Truist Buy
2025-11-20 アップグレード Leerink Partners Market Perform → Outperform
2025-11-19 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
09:02 AM

AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing Investigation - marketscreener.com

09:02 AM
pulisher
Mar 24, 2026

Agios Pharmaceuticals stock declines 23% in 6 months: Here's why - MSN

Mar 24, 2026
pulisher
Mar 24, 2026

The Gross Law Firm Announces an Investigation on Behalf of Agios Pharmaceuticals, Inc. (AGIO) Shareholders Who May Have Been Affected by Fraud - PR Newswire

Mar 24, 2026
pulisher
Mar 22, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Mar 22, 2026
pulisher
Mar 21, 2026

AGIO PE Ratio & Valuation, Is AGIO Overvalued - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

AGIO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

Agios falls as Leerink cites deaths linked to lead asset Pyrukynd - MSN

Mar 21, 2026
pulisher
Mar 18, 2026

Agios Pharmaceuticals (AGIO) reports Q4 loss, beats revenue estimates - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios P - GuruFocus

Mar 18, 2026
pulisher
Mar 18, 2026

Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis - Barchart.com

Mar 18, 2026
pulisher
Mar 18, 2026

Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - Yahoo Finance

Mar 18, 2026
pulisher
Mar 18, 2026

ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - marketscreener.com

Mar 18, 2026
pulisher
Mar 17, 2026

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gro - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gross Law Firm Regarding an Ongoing Investigation - PR Newswire

Mar 17, 2026
pulisher
Mar 17, 2026

Liquidity Mapping Around (AGIO) Price Events - Stock Traders Daily

Mar 17, 2026
pulisher
Mar 16, 2026

HighVista Strategies LLC Buys 125,171 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Does UAE Thalassemia Approval for PYRUKYND Reframe the Bull Case for Agios Pharmaceuticals (AGIO)? - simplywall.st

Mar 16, 2026
pulisher
Mar 14, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Cut to Sell at Wall Street Zen - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Cantor Fitzgerald Keeps Overweight on Agios Pharmaceuticals, Inc. (AGIO) Mar 2026 - Meyka

Mar 13, 2026
pulisher
Mar 12, 2026

AGIO SEC FilingsAgios Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Agios Pharmaceuticals (AGIO) price target decreased by 34.97% to 32.77 - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com

Mar 12, 2026
pulisher
Mar 11, 2026

A Look At Agios Pharmaceuticals (AGIO) Valuation After PYRUKYND Approval And GCC Expansion - simplywall.st

Mar 11, 2026
pulisher
Mar 11, 2026

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - Morningstar

Mar 11, 2026
pulisher
Mar 11, 2026

Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law ViolationsContact The Gross Law Firm for Details- AGIO - lelezard.com

Mar 11, 2026
pulisher
Mar 10, 2026

Agios Pharmaceuticals, Inc. Investigated Regarding Potential Sec - GuruFocus

Mar 10, 2026
pulisher
Mar 09, 2026

Agios Pharmaceuticals (AGIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 09, 2026
pulisher
Mar 09, 2026

Agios (NASDAQ: AGIO) executive sells 2,959 shares to cover RSU tax - Stock Titan

Mar 09, 2026
pulisher
Mar 09, 2026

Agios Pharmaceuticals: Worthy Of Accumulation (NASDAQ:AGIO) - Seeking Alpha

Mar 09, 2026
pulisher
Mar 09, 2026

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides - AOL.com

Mar 09, 2026
pulisher
Mar 09, 2026

Zacks Research Analysts Lift Earnings Estimates for AGIO - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

Stock Analysis: Is Agios Pharmaceuticals Inc. stock showing strong momentum2026 Fundamental Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 07, 2026

AGIO Earnings History & Surprises | EPS & Revenue Results | AGIOS PHARMACEUTICALS INC (NASDAQ:AGIO) - ChartMill

Mar 07, 2026
pulisher
Mar 07, 2026

Why Agios Pharmaceuticals Inc. stock could benefit from AI revolutionShort Setup & Risk Managed Investment Entry Signals - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash - AOL.com

Mar 06, 2026
pulisher
Mar 06, 2026

FY2028 Earnings Forecast for AGIO Issued By Zacks Research - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

Why (AGIO) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Mar 05, 2026
pulisher
Mar 05, 2026

Insider Sell Alert: Washburn Theodore James Jr. Sells Shares of Agios Pharmaceuticals Inc (AGIO) - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

AGIO: Citigroup Raises Price Target Amidst Continuous Buy Ratings | AGIO Stock News - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Citigroup Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) Stock - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Agios Pharmaceuticals (AGIO) Target Price Raised by Citi - GuruFocus

Mar 05, 2026
pulisher
Mar 04, 2026

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors o - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

How The Agios Pharmaceuticals (AGIO) Story Is Shifting After Aqvesme Approval And New Targets - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsAGIO – Company AnnouncementFT.com - Financial Times

Mar 04, 2026
pulisher
Mar 04, 2026

Agios Pharmaceuticals, Inc. $AGIO Shares Sold by TD Asset Management Inc - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Agios Pharmaceuticals (AGIO) Is Down 6.3% After UAE Clears PYRUKYND As First Thalassemia Drug - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact The Gross Law Firm Regarding Potential Securities Law ViolationsAGIO - StreetInsider

Mar 04, 2026
pulisher
Mar 03, 2026

Agios (AGIO) CMO logs tax-driven share sales and major new equity awards - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Agios (NASDAQ: AGIO) CEO Brian Goff receives large equity grants, sells shares for tax withholding - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

AGIOS (AGIO) legal chief gains RSUs, options and sells shares for taxes - Stock Titan

Mar 03, 2026

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
大文字化:     |  ボリューム (24 時間):